Systematic review of central nervous system anomalies in incontinentia pigmenti

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Minić, Snežana ^a   Trpinac, Dušan ^b   Obradović, Miljana ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

CNS anomalies; Diagnostic criteria; IKBKG gene; Incontinentia pigmenti; Systematic review

Indexed keywords

BRAIN ATROPHY; BRAIN INFARCTION; BRAIN NECROSIS; CENTRAL NERVOUS SYSTEM MALFORMATION; CORPUS CALLOSUM; DISEASE SEVERITY; EXON; GENE DELETION; HUMAN; INCONTINENTIA PIGMENTI; MENTAL DEFICIENCY; MICROCEPHALY; MOTOR DYSFUNCTION; NEUROIMAGING; RETINA MALFORMATION; REVIEW; SEIZURE; SYSTEMATIC REVIEW;

CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; INCONTINENTIA PIGMENTI; MALE;

EID: 84874062548     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-25     Document Type: Review

References (47)

1. Orphanet Report Series-Prevalence of rare diseases: Bibliographic data-May 2012-Number 1 [ http://www.orpha.net/orphacom/cahiers/docs/GB/ Prevalence-of-rare-diseases-by-alphabetical-list.pdf ]
2. Scheuerle A, Ursini MV, Incontinentia pigmenti (Bloch-Sulzberger syndrome) University of Washington, Seattle (WA): GeneReviews 2008 Feb, 22 pp. [ http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=i-p.]
3. Incontinentia pigmenti (Bloch-Sulzberger syndrome). Landy SJ, Donnai D, J Med Genet 1993 30 53 59 10.1136/jmg.30.1.53 8423608 (Pubitemid 23067559)
4. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. Berlin AL, Paller AS, Chan LS, J Am Acad Dermatol 2002 47 169 187 10.1067/mjd.2002.125949 12140463
5. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, Israël A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A, Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D'Urso M, Woffendin H, Jakins T, Donnai D, Stewart H, Kenwrick SJ, Aradhya S, Yamagata T, Levy M, Lewis RA, Nelson DL, Nature 2000 405 466 472 10.1038/35013114 10839543 (Pubitemid 30367424)
6. Mutations in the NF-κB signaling pathway: implication for human disease. Courtois G, Gilmore TD, Oncogene 2006 25 6831 6843 10.1038/sj.onc. 1209939 17072331 (Pubitemid 44657855)
7. NF-κB in neuronal plasticity and neurodegenerative disorders. Mattson MP, Camandola S, J Clin Invest 2001 107 247 254 10.1172/JCI11916 11160145 (Pubitemid 32162153)
8. Roles for NF-κB in nerve cell survival, plasticity, and disease. Mattson MP, Meffert MK, Cell Death Differ 2006 13 852 860 10.1038/sj.cdd.4401837 16397579
9. NF-κB in neurons: behavioral and physiologic roles in nervous system function. Levenson JM, Pizzi M, Sweatt JD, NF-kB/Rel transcription factor family Georgtown and New York: Landes Bioscience and Springer Science+Business Media, Liou H-C, 2006 147 161
10. A recurrent deletion in the ubiquitously expressed NEMO (IKK-γ) gene accounts for the vast majority of incontinentia pigmenti mutations. Aradhya S, Woffendin H, Jakins T, Bardaro T, Esposito T, Smahi A, Shaw C, Levy M, Munnich A, D'Urso M, Lewis RA, Kenwrick S, Nelson DL, Hum Mol Genet 2001 10 2171 2179 10.1093/hmg/10.19.2171 11590134 (Pubitemid 32998829)
11. Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Sebban-Benin H, Pescatore A, Fusco F, Pascuale V, Gautheron J, Yamaoka S, Moncla A, Ursini MV, Hum Mol Genet 2007 16 2805 2815 10.1093/hmg/ddm237 17728323 (Pubitemid 350048380)
12. Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-κB activation. Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G, Israël A, Courtois G, D'Urso M, Ursini MV, Hum Mol Genet 2004 13 1763 1773 10.1093/hmg/ddh192 15229184 (Pubitemid 39173445)
13. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations. Fusco F, Pescatore A, Bal E, Ghoul A, Paciolla M, Lioi MB, D'Urso M, Rabia SH, Bodemer C, Bonnefont JP, Munnich A, Miano MG, Smahi A, Ursini MV, Hum Mutat 2008 29 595 604 10.1002/humu.20739 18350553 (Pubitemid 351614582)
14. Incontinentia pigmenti: clinical and neuroimaging findings in a series of 12 patients. Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Martinez V, Neurologia 2006 21 239 248 16788866 (Pubitemid 44060694)
15. Incontinentia pigmenti: a world statistical analysis. Carney RG, Arch Dermatol 1976 112 535 542 10.1001/archderm.1976.01630280059017 1267462
16. Peculiar pigmentation of the skin of an infant. Garrod AE, Trans Clin Soc London 1906 39 216
17. Sachs L, Applied statistics New York: Springer-Verlag 2 1984
18. Incontinence of pigment. Rola M, Martins T, Melo MJ, Gomes R, Roseira J, Souto A, An Pediatr (Barc) 2004 60 601 602 10.1157/13062338 (Pubitemid 38998295)
19. A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency. Martinez-Pomar N, Munoz-Saa I, Heine-Suner A, Martin A, Smahi A, Metamoros N, Hum Genet 2005 118 458 465 10.1007/s00439-005-0068-y 16228229 (Pubitemid 43091216)
20. Clinical study of 40 cases of incontinentia pigmenti. Hadj-Rabia S, Froidevaux D, Bodak N, Hamel-Teillac D, Smahi A, Touil Y, Fraitag S, de Prost Y, Bodemer C, Arch Dermatol 2003 139 1163 1170 10.1001/archderm.139.9.1163 12975158 (Pubitemid 37128378)
21. Incontinentia pigmenti: clinical observation of 40 Korean cases. Kim BJ, Shin HS, Won CH, Lee JH, Kim KH, Kim MN, Ro BI, Kwon OS, J Korean Med Sci 2006 21 474 477 10.3346/jkms.2006.21.3.474 16778392
22. Eurocat Prevalence Data Tables [ http://www.eurocat-network.eu/prevdata/ resultsPdf.aspx?title=B3&allanom=false&allregf=true&allrega= true&anomalies=8&winx=1256&winy=894 ]
23. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Theodore WH, Spencer SS, Wiebe S, Langfitt JT, Ali A, Shafer PP, Berg AT, Vickrey BG, Epilepsia 2006 47 1700 1722 10.1111/j.1528-1167.2006.00633.x 17054693 (Pubitemid 44556405)
24. «Idiopathic» mental retardation and new chromosomal abnormalities. Galasso C, Lo-Castro A, El-Malhany N, Curatolo P, Ital J Pediatr 2010 36 17 10.1186/1824-7288-36-17 20152051
25. Clinical diagnosis of incontinentia pigmenti in a cohort of male patients. Fusco F, Fimiani G, Tadini G, Michele D, Ursini MV, J Am Acad Dermatol 2007 56 264 267 10.1016/j.jaad.2006.09.019 17224368 (Pubitemid 46074254)
26. Atteinte neurologique létale au cours d'une incontinentia pigmenti. Bachevalier F, Marchal C, Di Cesare MP, Antunes A, Truchetet F, Ann Dermatol Venereol 2003 130 1139 1142 AD-12-2003-130-12-0151-9638-101019-ART8 14724517 (Pubitemid 38044482)
27. Les 1ésions cérébrales de l'incontinentia pigmenti. A propos d'un cas anatomique. Hauw JJ, Perié G, Bonnette J, Escourolle R, Acta Neuropathol 1977 38 159 162 10.1007/BF00688564 878852 (Pubitemid 8101030)
28. Incontinentia pigmenti (Bloch-Sulzberger syndrome) in neonates. Buinauskiene J, Buinauskaite E, Valiukeviciene S, Medicina (Kaunas) 2005 41 496 499
29. The rare phakomatoses. Edelstein S, Naidich TP, Newton TH, Pediatric neuroradiology. Part I Berlin-Heidelberg: Springer-Verlag, Tortori-Donati P, Rossi A, 2005 819 854
30. Neurological findings in incontinentia pigmenti; a review. Meuwissen MEC, Mancini GMS, Eur J Med Genet 2012 55 323 331 10.1016/j.ejmg.2012.04.007 22564885
31. Bilateral cerebrovascular accidents in incontinentia pigmenti. Fiorillo L, Sinclair DB, O'Byrne ML, Krol AL, Pediatr Neurol 2003 29 66 68 10.1016/S0887-8994(03)00144-9 13679126 (Pubitemid 37117181)
32. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Hennel SJ, Ekert PG, Volpe JJ, Inder TE, Pediatr Neurol 2003 29 148 150 10.1016/S0887-8994(03)00150-4 14580659 (Pubitemid 37324388)
33. NF-κB signalling requirement for brain myelin formation is shown by genotype/MRI phenotype correlations in patients with Xq28 duplications. Philippe O, Rio M, Malan V, Van Esch H, Baujat G, Bahi-Buisson N, Valayannopoulos V, Gesny R, Bonnefont JP, Munnich A, Froyen G, Amiel J, Boddaert N, Colleaux L, Eur J Hum Genet 2012 10.1038/ejhg.2012.140
34. Van der Knaap M, Valk J, Magnetic resonance of myelination and myelin disorders Berlin-Heidelberg: Springer 2005
35. Retinal cell apoptosis, microvascular changes and expression of connective tissue growth factor in experimental diabetic rats. Hu YB, Zhang JK, Sun ZY, Yuan ZG, Liu YM, Mao CJ, Yan H, Zhonghua Yan Ke Za Zhi 2011 47 521 526 21914267
36. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G, Nomenclature Committee on Cell Death 2009, Cell Death Differ 2009 16 3 11 10.1038/cdd.2008.150 18846107
37. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nuñez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, et al. Cell Death Differ 2012 19 107 120 10.1038/cdd.2011.96 21760595
38. Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Gu X, El-Remessy AB, Brooks SE, Al-Shabrawey M, Tsai NT, Caldwell RB, Am J Physiol Cell Physiol 2003 285 546 C554 10.1152/ajpcell.00424.2002 12736139
39. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celstin J, Leder P, Luster AD, Nat Med 1996 2 449 456 10.1038/nm0496-449 8597956 (Pubitemid 26193013)
40. Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti. Jean-Baptiste S, O'Toole EA, Chen M, Guitart J, Paller A, Chan LS, Clin Exp Immunol 2002 127 470 478 10.1046/j.1365-2249.2002.01755.x 11966763 (Pubitemid 34437818)
41. The skin is not the predominant problem in incontinentia pigmenti. Goldberg MF, Arch Dermatol 2004 140 748 750 10.1001/archderm.140.6.748 15210470 (Pubitemid 38747295)
42. Ocular anomalies in incontinentia pigmenti-literature review and meta-analysis. Minić S, Obradović M, Kovačević I, Trpinac D, Srp Arh Celok Lek 2010 138 408 413 10.2298/SARH1008408M 20842883
43. Dental and oral anomalies in incontinentia pigmenti: a systematic review. Minić S, Trpinac D, Gabriel H, Gencik M, Obradović M, Clin Oral Invest 2013 17 1 8 10.1007/s00784-012-0721-5
44. Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms. Fusco F, Paciolla M, Napolitano F, Pescatore A, D'Addario I, Bal E, Lioi MB, Smahi A, Miano MG, Ursini MV, Hum Mol Genet 2012 21 1260 1271 10.1093/hmg/ddr556 22121116
45. XLMR genes: update 2007. Chiurazzi P, Schwartz CE, Gecz J, Neri G, Eur J Hum Genet 2008 16 422 434 10.1038/sj.ejhg.5201994 18197188 (Pubitemid 351420375)
46. Genetics and pathophysiology of mental retardation. Chelly J, Khelfaoui M, Francis F, Chérif B, Bienvenu T, Eur J Hum Genet 2006 14 701 713 10.1038/sj.ejhg.5201595 16721406 (Pubitemid 43797267)
47. Clinical and histologic features of incontinentia pigmenti in adults with nuclear factor-κB essential modulator gene mutations. Hadj-Rabia S, Rimella A, Smahi A, Fraitag S, Hamel-Teillac D, Bonnefont JP, de Prost Y, Bodemer C, J Am Acad Dermatol 2011 64 508 515 10.1016/j.jaad.2010.01.045 21255870